SCHEMBL24118244

SCHEMBL24118244

C=C(CCNC(=O)c1ccc(C)c(F)c1)[C@@H](C)C(=O)Nc1ccc(F)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.51
▸ POLB P06746 2/20 0.51
▸ KCNQ3 O43525 2/20 0.44
▸ KCNQ2 O43526 2/20 0.44
▸ KCNE1 P15382 2/20 0.44
▸ KCNQ1 P51787 2/20 0.44
▸ IDO1 P14902 2/20 0.44
▸ HDAC1 Q13547 3/20 0.43
▸ HDAC6 Q9UBN7 1/20 0.43
▸ KCNQ5 Q9NR82 1/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ LMNA P02545 2/20 0.42
▸ KDM4E B2RXH2 2/20 0.42
▸ NAMPT P43490 3/20 0.42
▸ MAPT P10636 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ HDAC3 O15379 2/20 0.39
▸ HDAC2 Q92769 2/20 0.39
▸ NCOR2 Q9Y618 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24118311 0.92 ALDH1A1 (0.46) ALDH1A1POLBIDO1HDAC1MEN1
SCHEMBL24118073 0.92 ALDH1A1 (0.46) ALDH1A1POLBIDO1HDAC1MEN1
SCHEMBL24117949 0.91 IDO1 (0.53) ALDH1A1POLBKCNQ3KCNQ2KCNE1
SCHEMBL24117930 0.90 CYP1A2 (0.49) ALDH1A1POLBIDO1MEN1KMT2A
SCHEMBL24118064 0.88 IDO1 (0.46) ALDH1A1POLBKCNQ3KCNQ2KCNE1
SCHEMBL24118386 0.88 MEN1 (0.42) ALDH1A1POLBIDO1HDAC1MEN1
SCHEMBL24118259 0.88 POLB (0.44) ALDH1A1POLBIDO1MEN1KMT2A
SCHEMBL24118272 0.85 MEN1 (0.44) ALDH1A1POLBIDO1MEN1KMT2A
SCHEMBL24118616 0.85 NAMPT (0.41) ALDH1A1POLBMEN1KMT2ALMNA
SCHEMBL24118248 0.84 POLB (0.56) POLBHDAC1HDAC6MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210393600-A1 Novel [1.1.1] Bicyclo Compounds as Indoleamine 2,3-Dioxygenase Inhibitors MERCK SHARP & DOHME CORP. (US) 2021-12-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210393600-A1 Novel [1.1.1] Bicyclo Compounds as Indoleamine 2,3-Dioxygenase Inhibitors IDO1, IDO2, TPH1 ALDH1A1 144/4885POLB 1950/4885KCNQ3 4341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback